High Sensitivity Quantitation of Nitrosamine Genotoxic Impurities: LC-MS Analysis of Ranitidine Drug Product using the Waters ACQUITY UPLC I-Class/Xevo TQ-XS Tandem Quadrupole Mass Spectrometer

Library Number:
APNT135068607
Part Number:
720006899EN
Author(s):
Mary Trudeau Lame, Lindsay Hatch
Source:
Waters
Content Type:
Application Notes
Content Subtype:
Application Notes
Related Products:
 
 
 
 

Use of the reversed-phase HSS T3 Column provided excellent retentivity for nitrosamine impurities, particularly the most polar nitrosamine, NDMA, while also providing separation from ranitidine API. Detection using a tandem quadrupole MS system with MRM analysis using atmospheric pressure chemical ionization (APCI), provided a 10X fold sensitivity improvement compared to electrospray ionization (ESI) for the nitrosamines. With this developed assay, LLOQs 0.025–0.1 ng/mL (<3 pg/mL on-column), for the various nitrosamine impurities were achieved for neat standard solutions, DS, and DP, with recoveries between 85–115% for the calibration points. The specificity, sensitivity, and broad linear dynamic range of this developed assay easily detected 0.1 ng/mL (0.0033 ppm, relative to 30 mg/mL DP or DS) of the nitrosamines in ranitidine drug product. Using this method, endogenous levels of NDMA from a prepared ranitidine drug tablet were detected and calculated to be 28 ng/mL (~1 ppm). The performance of this developed assay demonstrates a highly sensitive, accurate, and robust method for simultaneous nitrosamine impurity detection and quantitation, easily achieving regulatory guidance threshold values for these nitrosamine impurities in drug substance and drug product. 


Title Format File Size
Download PDF PDF 1213.39kB